Using breast cancer cells lines (MCF-7 and HCC1428), we demonstrated that estrogen may act via Gli1 to promote CSC development and EMT in ER-positive breast cancer cells, which may contribute to breast tumor malignancy. Here, GLI1 is linked to breast cancer.